Atlas Trials

Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery

Clinical trial NCT02535351 · TERMINATED

Trial details

NCT number
NCT02535351
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Clear-cell Metastatic Renal Cell Carcinoma
Start date
2015-11-01
Primary completion
2018-09-28
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.